These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 23490443)
1. Cerenkov luminescence tomography of aminopeptidase N (APN/CD13) expression in mice bearing HT1080 tumors. Hu Z; Yang W; Ma X; Ma W; Qu X; Liang J; Wang J; Tian J Mol Imaging; 2013 May; 12(3):173-81. PubMed ID: 23490443 [TBL] [Abstract][Full Text] [Related]
2. In vivo optical imaging of CD13/APN-expression in tumor xenografts. von Wallbrunn A; Waldeck J; Höltke C; Zühlsdorf M; Mesters R; Heindel W; Schäfers M; Bremer C J Biomed Opt; 2008; 13(1):011007. PubMed ID: 18315356 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression. Chen K; Ma W; Li G; Wang J; Yang W; Yap LP; Hughes LD; Park R; Conti PS Mol Pharm; 2013 Jan; 10(1):417-27. PubMed ID: 23190134 [TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR). Máté G; Kertész I; Enyedi KN; Mező G; Angyal J; Vasas N; Kis A; Szabó É; Emri M; Bíró T; Galuska L; Trencsényi G Eur J Pharm Sci; 2015 Mar; 69():61-71. PubMed ID: 25592229 [TBL] [Abstract][Full Text] [Related]
5. Kis A; Dénes N; Szabó JP; Arató V; Beke L; Matolay O; Enyedi KN; Méhes G; Mező G; Bai P; Kertész I; Trencsényi G Biomed Res Int; 2021; 2021():6642973. PubMed ID: 33778075 [TBL] [Abstract][Full Text] [Related]
6. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET. Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818 [TBL] [Abstract][Full Text] [Related]
7. 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13). Cui SX; Zhang HL; Xu WF; Qu XJ Eur J Pharmacol; 2014 Jul; 734():50-9. PubMed ID: 24726845 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of 99mTc-probestin for imaging APN expressing tumors by SPECT. Pathuri G; Hedrick AF; Awasthi V; Ihnat MA; Gali H Bioorg Med Chem Lett; 2013 Sep; 23(18):5049-52. PubMed ID: 23937983 [TBL] [Abstract][Full Text] [Related]
9. In vivo assessment of aminopeptidase N (APN/CD13) specificity of different Kis A; Dénes N; Szabó JP; Arató V; Jószai I; Enyedi KN; Lakatos S; Garai I; Mező G; Kertész I; Trencsényi G Int J Pharm; 2020 Nov; 589():119881. PubMed ID: 32946975 [TBL] [Abstract][Full Text] [Related]
10. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects. Garde SV; Forté AJ; Ge M; Lepekhin EA; Panchal CJ; Rabbani SA; Wu JJ Anticancer Drugs; 2007 Nov; 18(10):1189-200. PubMed ID: 17893520 [TBL] [Abstract][Full Text] [Related]
11. NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells. Wang X; Wang Y; Chen X; Wang J; Zhang X; Zhang Q J Control Release; 2009 Oct; 139(1):56-62. PubMed ID: 19470394 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel Tc-99m labeled NGR-containing hexapeptides as tumor imaging agents. Kim DW; Kim WH; Kim MH; Kim CG J Labelled Comp Radiopharm; 2015 Feb; 58(2):30-5. PubMed ID: 25583160 [TBL] [Abstract][Full Text] [Related]
13. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo. Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036 [TBL] [Abstract][Full Text] [Related]
14. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model. Akita S; Hattori N; Masuda T; Horimasu Y; Nakashima T; Iwamoto H; Fujitaka K; Miyake M; Kohno N Cancer Sci; 2015 Jul; 106(7):921-8. PubMed ID: 25950387 [TBL] [Abstract][Full Text] [Related]
15. APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes. Dunne M; Zheng J; Rosenblat J; Jaffray DA; Allen C J Control Release; 2011 Sep; 154(3):298-305. PubMed ID: 21640146 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic Performance Evaluation of Képes Z; Arató V; Szabó JP; Gyuricza B; Szücs D; Hajdu I; Fekete A; Bruchertseifer F; Szikra D; Trencsényi G Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839813 [TBL] [Abstract][Full Text] [Related]
18. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Curnis F; Arrigoni G; Sacchi A; Fischetti L; Arap W; Pasqualini R; Corti A Cancer Res; 2002 Feb; 62(3):867-74. PubMed ID: 11830545 [TBL] [Abstract][Full Text] [Related]
19. An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity. Zheng YB; Shang BY; Li Y; Zhen YS Biomed Pharmacother; 2013 Mar; 67(2):164-71. PubMed ID: 23206754 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of (188)Re-labeled NGR-VEGI protein for radioimaging and radiotherapy in mice bearing human fibrosarcoma HT-1080 xenografts. Ma W; Shao Y; Yang W; Li G; Zhang Y; Zhang M; Zuo C; Chen K; Wang J Tumour Biol; 2016 Jul; 37(7):9121-9. PubMed ID: 26768609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]